CN103566003B - Pharmaceutical composition for treating cesarean postpartum urinary retention - Google Patents

Pharmaceutical composition for treating cesarean postpartum urinary retention Download PDF

Info

Publication number
CN103566003B
CN103566003B CN201310524834.8A CN201310524834A CN103566003B CN 103566003 B CN103566003 B CN 103566003B CN 201310524834 A CN201310524834 A CN 201310524834A CN 103566003 B CN103566003 B CN 103566003B
Authority
CN
China
Prior art keywords
grams
pharmaceutical composition
cesarean
urinary retention
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310524834.8A
Other languages
Chinese (zh)
Other versions
CN103566003A (en
Inventor
仇素平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310524834.8A priority Critical patent/CN103566003B/en
Publication of CN103566003A publication Critical patent/CN103566003A/en
Application granted granted Critical
Publication of CN103566003B publication Critical patent/CN103566003B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a pharmaceutical composition for treating cesarean postpartum urinary retention. The pharmaceutical composition is prepared through the following steps: taking Kalimeris integrifolia, cornus macrophylla wall, radix puerariae, red chopsticks, sabia parviflora wall.ex roxb, cicada slough, populus tomentosa, honeysuckle, lespedeza, pawpaw, herbs of ghostplant wormwood, radix achyranthis bidentatae, chimonanthus nitens, zaocys dhumnade, neat viburnum herbs and cortex acanthopanacis, adding water, heating in a sealed container at the temperature of 80 DEG C for 3h, cooling to the room temperature, and filtering to obtain a filtrate, i.e., the pharmaceutical composition. The pharmaceutical composition disclosed by the invention is prepared from pure traditional Chinese medicines by using the traditional method, so that the drug property is remained, the curative effect is exact, and the pharmaceutical composition can be used for effectively treating cesarean postpartum urinary retention.

Description

A kind of pharmaceutical composition for the treatment of cesarean postpartum urinary retention
Technical field
The present invention relates to department of obstetrics and gynecology field, specifically, relate to the pharmaceutical composition that official's postpartum retention of urine is cutd open in a kind for the treatment of.
Background technology
Filling of bladder in puerperal and can not voluntary micturition or dysuriac, claim postpartum retention of urine, with primipara, difficult labour, stages of labor is long and operation practise midwifery person is common, is common complication in puerperal.Postpartum retention of urine can be divided into completeness and partial two kinds, and the former refers to and oneself can not urinate completely, and the latter refers to only can solve part urine.Postpartum retention of urine not only bladder excessive is expanded and affects uterine contraction, causes vaginal hemorrhage amount to increase, still causes one of key factor of urinary system infection in puerperal, therefore answer positive treatment.
Summary of the invention
The object of this invention is to provide a kind of pharmaceutical composition for the treatment of cesarean postpartum urinary retention.
In order to realize object of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of cesarean postpartum urinary retention, this pharmaceutical composition obtains through the following steps: get Kalimeris integrifolia 9 grams, Lignum corni macrophyllae 7 grams, Radix Puerariae 9 grams, Herba Epilobii Angustifoii 8 grams, little cyanine Radix seu Caulis fici Martinii 9 grams, Periostracum Cicadae 3 grams, Cortex Populi Tomentosae 7 grams, Flos Lonicerae 9 grams, Caulis Seu Folium Lespedezae Bicoloris 6 grams, Fructus Chaenomelis 9 grams, Herba artemisiae lactiflorae 5 grams, Radix Achyranthis Bidentatae 6 grams, Chimonanthusn itens Oliv. 5 grams, Zaocys 3 grams, Viburnum propinquum Hemsl. 7 grams and Cortex Acanthopancis 6 grams, add 10000 ml waters, heat 3 hours at 80 DEG C in the container of sealing, be cooled to room temperature, filter, filtrate is described pharmaceutical composition.
The pharmaceutical composition that the method for the invention obtains, with pure traditional Chinese medicine, adopts traditional manufacture method, remains the property of medicine of medicine, clear curative effect, effectively can treat cesarean postpartum urinary retention.
Accompanying drawing explanation
According to " Chinese medicine voluminous dictionary " second edition, being described as follows of some Chinese crude drugs used in the present invention:
Fig. 1 is the explanation of Kalimeris integrifolia;
Fig. 2 is the explanation of Lignum corni macrophyllae;
Fig. 3 is the explanation of Herba Epilobii Angustifoii;
Fig. 4 is the explanation of little cyanine Radix seu Caulis fici Martinii;
Fig. 5 is the explanation of Cortex Populi Tomentosae;
Fig. 6 is the explanation of Caulis Seu Folium Lespedezae Bicoloris;
Fig. 7 is the explanation of Herba artemisiae lactiflorae;
Fig. 8 is the explanation of Chimonanthusn itens Oliv.;
Fig. 9 is the explanation of Viburnum propinquum Hemsl..
Detailed description of the invention
Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Kalimeris integrifolia 9 grams, Lignum corni macrophyllae 7 grams, Radix Puerariae 9 grams, Herba Epilobii Angustifoii 8 grams, little cyanine Radix seu Caulis fici Martinii 9 grams, Periostracum Cicadae 3 grams, Cortex Populi Tomentosae 7 grams, Flos Lonicerae 9 grams, Caulis Seu Folium Lespedezae Bicoloris 6 grams, Fructus Chaenomelis 9 grams, Herba artemisiae lactiflorae 5 grams, Radix Achyranthis Bidentatae 6 grams, Chimonanthusn itens Oliv. 5 grams, Zaocys 3 grams, Viburnum propinquum Hemsl. 7 grams and Cortex Acanthopancis 6 grams, add 10000 ml waters, heat 3 hours at 80 DEG C in the container of sealing, be cooled to room temperature, filter, filtrate is decoction of the present invention.
Experimental example
Pharmaceutical composition efficient combination of the present invention, coordinates mutually, effectively can reach the object for the treatment of cesarean postpartum urinary retention, and side effect is less.The above results is clinical data sufficient proof, and interrelated data is as follows.
1. object and method
1.1 objects: add epidural at lumbar anesthesia and anaesthetize the childbirth of descending cesarean section, lying in woman urine oedema 60 example occurs after pulling out urinary catheter 24h.23 ~ 37 years old age.
1.2 methods: adopt the decoction of preparation in embodiment 1 to treat, oral 200 milliliters.
1.3 curative effect determinate standards: in 4h, voluntary micturition is successfully, the 4h person that do not urinate yet is unsuccessfully.
2 results
2.1 treatment success rates: in medication 4h, 60 routine puerperas all urinate successfully, success rate 100%.
2.2 treatments are to required time of urinating: average time is 42.53 ± 21.51min.
2.3 untoward reaction and toxic and side effects supervision: by detect puerpera blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Finding that the systolic pressure of 60 routine puerperas is at 90-140mmHg, diastolic pressure 60-90mmHg, pulse is 60-100 time/per minute, all within normal range, and there is not Nausea and vomiting, dizzy clinical symptoms in blood pressure and pulse.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that this medicine does not have obvious toxic and side effects for human body.

Claims (1)

1. the purposes of a compositions in the medicine of preparation treatment cesarean postpartum urinary retention, it is characterized in that, said composition obtains through the following steps: get Kalimeris integrifolia 9 grams, Lignum corni macrophyllae 7 grams, Radix Puerariae 9 grams, Herba Epilobii Angustifoii 8 grams, little cyanine Radix seu Caulis fici Martinii 9 grams, Periostracum Cicadae 3 grams, Cortex Populi Tomentosae 7 grams, Flos Lonicerae 9 grams, Caulis Seu Folium Lespedezae Bicoloris 6 grams, Fructus Chaenomelis 9 grams, Herba artemisiae lactiflorae 5 grams, Radix Achyranthis Bidentatae 6 grams, Chimonanthusn itens Oliv. 5 grams, Zaocys 3 grams, Viburnum propinquum Hemsl. 7 grams and Cortex Acanthopancis 6 grams, add 10000 ml waters, heat 3 hours at 80 DEG C in the container of sealing, be cooled to room temperature, filter, filtrate is described medicine.
CN201310524834.8A 2013-10-31 2013-10-31 Pharmaceutical composition for treating cesarean postpartum urinary retention Expired - Fee Related CN103566003B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310524834.8A CN103566003B (en) 2013-10-31 2013-10-31 Pharmaceutical composition for treating cesarean postpartum urinary retention

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310524834.8A CN103566003B (en) 2013-10-31 2013-10-31 Pharmaceutical composition for treating cesarean postpartum urinary retention

Publications (2)

Publication Number Publication Date
CN103566003A CN103566003A (en) 2014-02-12
CN103566003B true CN103566003B (en) 2015-04-01

Family

ID=50039284

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310524834.8A Expired - Fee Related CN103566003B (en) 2013-10-31 2013-10-31 Pharmaceutical composition for treating cesarean postpartum urinary retention

Country Status (1)

Country Link
CN (1) CN103566003B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104840678A (en) * 2015-05-04 2015-08-19 秦连芝 Traditional Chinese medicine enema for curing urinary retention after caesarean procedure

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
产后尿潴留中医治疗近况;李国庆;《天津中医》;19931231(第3期);16-18 *
葛根在妇产科临床应用举要;金真;《江苏中医药》;20031231;第24卷(第2期);44 *
蝉蜕新用;张青春等;《山东中医杂志》;19990930;第18卷(第9期);416-417 *

Also Published As

Publication number Publication date
CN103566003A (en) 2014-02-12

Similar Documents

Publication Publication Date Title
CN102370725B (en) A kind of compound Chinese medicinal preparation treating chronic pelvic inflammatory disease and preparation method thereof
CN102743501B (en) A kind of prescription for the treatment of qi-deficiency type uterine prolapse
CN103349766B (en) Pharmaceutical composition for endless postpartum lochia
CN103638511A (en) Postpartum stasis removing particles
CN103142879B (en) Traditional Chinese medicine for treating rubella
CN104435519B (en) A kind of pharmaceutical composition for treating primary dysmenorrhea
CN103800843B (en) A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease
CN103566003B (en) Pharmaceutical composition for treating cesarean postpartum urinary retention
CN102872362B (en) Traditional Chinese medicine for treating chronic cholecystitis
CN104873706A (en) Traditional Chinese medicine composition for treating uterine cold infertility
CN103550465B (en) A kind of preparation method for the treatment of the pharmaceutical composition of cesarean postpartum urinary retention
CN104013704B (en) Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition
CN104013901A (en) Medicament for treating pelvic inflammation
CN104013784A (en) Medicament for treating pelvic inflammation
CN103536790A (en) Traditional Chinese medicine for treating acute icteric hepatitis
CN104042984A (en) Medicament for treating pelvic inflammation
CN105999116B (en) Traditional Chinese medicine enema prescription for treating chronic pelvic pain
CN104013893A (en) Medicament for treating pelvic inflammation
CN105456805A (en) Traditional Chinese medicine composition for treating blood heat internal disturbance type postpartum flooding
CN103550448A (en) Traditional Chinese medicine preparation for treating chronic pelvic inflammatory disease
CN105030985A (en) Traditional Chinese medicine composition with effects of tonifying deficiency and promoting lactation and preparation method of traditional Chinese medicine composition
CN104013857A (en) Medicament for treating pelvic inflammation
CN104042899A (en) Medicament for treating ulcerative colitis (UC)
CN104436064A (en) Pharmaceutical composition for treating dysmenorrhea
CN104056028A (en) Medicament for treating ulcerative colitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150401

Termination date: 20151031

EXPY Termination of patent right or utility model